Standards Reference
6,6-Dimethyl-2-propyl-3-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-3,6-dihydro-4H-furo[3,4-d]imidazol-4-one (MM1317.02)
Sinônimos: 6,6-Dimethyl-2-propyl-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-3,6-dihydro-4H-furo[3,4-d]imidazol-4-one, Olmesartan Medoxomil Imp. B (EP), 4H-Furo[3,4-d]imidazol-4-one, 3,6-dihydro-6,6-dimethyl-2-propyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 4H-Furo[3,4-d]imidazol-4-one, 3,6-dihydro-6,6-dimethyl-2-propyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI), 1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one, Olmesartan Medoxomil RC A (USP), Olmesartan Medoxomil Related Compound A, Olmesartan Medoxomil Impurity B
Descrição EP: Olmesartan Medoxomil Impurity B
Código do Produto:
MM1317.02
Número CAS:
849206-43-5
Product Categories:
Cardiac drugs and beta blockers Impurity Reference Materials Mikromol
API Family:
Olmesartan Medoxomil
Product Types:
Impurity
Formato do Produto:
Neat
Fórmula Molecular:
Peso Molecular:
Choose quantity:
Quote Change Quantity Remove from QuoteNOTE: Click the "Quote" button to include this product in your quote.
NOTE: Click the "Change Quantity" button to change the quantity of this product in your quote.
NOTE: Click on the button "Remove from Quote" this product will be deleted from your quote.
